David Goeddel - Profile and Investment Details

Investor Profile

David Goeddel is a Venture Capital, Investor based in Burlingame, California, United States with a diverse investment portfolio that includes companies such as Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals, Peloton Therapeutics, Carmot Therapeutics, Kallyope, PTC Therapeutics, Seragon Pharmaceuticals, Immune Design, Sagimet Biosciences, Cyterix Pharmaceuticals, Hexagon Bio, Circle Pharma, Tenaya Therapeutics, IgenicaORIC Pharmaceuticals, Casma Therapeutics, Surrozen, Accent Therapeutics, ProNeurotech, Escient Pharmaceuticals, A2 Biotherapeutics, Effector Therapeutics, Gritstone Oncology, Revolution Medicines, Neurona Therapeutics, Rapt Therapeutics, Arcus Biosciences, Plexium, Synthekine, Nurix Therapeutics, Ribon Therapeutics, Flexus Biosciences, Aragon Pharmaceuticals, . Over time, David Goeddel has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether David Goeddel is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotechnology, Consumer Health, Electronic Health Records (EHR), Health and Hospital Services, Digital Health, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with David Goeddel, as their portfolio suggests a familiarity and interest in this area.

Understanding David Goeddel’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.